Clobetasol propionate usp 0.05

Safety and effectiveness of clobetasol propionate ointment in pediatric patients have not been established. Use in children under 12 years of age is not recommended. Because of a higher ratio of skin surface area to body mass, pediatric patients are at a greater risk than adults of HPA axis suppression and Cushing's syndrome when they are treated with topical corticosteroids. They are therefore also at greater risk of adrenal insufficiency during or after withdrawal of treatment. Adverse effects including striae have been reported with inappropriate use of topical corticosteroids in infants and children.

Clobetasol propionate usp 0.05

clobetasol propionate usp 0.05

Media:

clobetasol propionate usp 0.05clobetasol propionate usp 0.05clobetasol propionate usp 0.05clobetasol propionate usp 0.05clobetasol propionate usp 0.05